The inconsistent predictive value of candidate biomarkers, PD-L1 expression, tissue TMB, and the lack of serial tumor tissue for molecular and genomic profiling limit the application of PD-L1 expression and tissue TMB26. This evidence concerns the gene CD274 and neoplasm.